Clene envisions a new future for pharmaceuticals by utilizing therapeutic components in pristine, innovative nanostructures. The patented Clean-Surface Nanosuspension™ (CSN) technology generates immaculate nanocrystals at economically feasible rates. Through the amalgamation of high-purity metallic donor materials and high-quality water, CSN unleashes the potential of therapeutic nanoparticles and signifies a clear departure from the traditional model of small-molecule medications and large-molecule biologics.